Talibegron Hydrochloride

N/A

Report date: 2023/04/21 17:24:47
NME

Base Information

Drug NameTalibegron Hydrochloride
Drug Alias Name็›้…ธไป–ๅˆฉ่ด้š†talibegronumไป–ๅˆฉ่ด้š†็›้…ธ็›็›้…ธไป–ๅˆฉๅ‹ƒ้š†ไป–ๅˆฉๅ‹ƒ้š†็›้…ธ็› +[10]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksKEGG